#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neovascular age-related macular degeneration Infantile apnoea Herpes simplex Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Adenovirus infection Cerebral amyloid angiopathy Neuropathy peripheral Choroid melanoma Peritoneal mesothelioma malignant Anal squamous cell carcinoma Fabry's disease Infection in an immunocompromised host Inclusion body myositis Renal disorder Acute promyelocytic leukaemia More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Life with Disease Glycogen storage disease type I – Life with Disease Prader-Willi syndrome Ehlers-Danlos syndrome – Treatment MELAS syndrome – Basic Information Bronchiolitis obliterans syndrome – Trials in Disease Pituitary-dependent Cushing’s syndrome Soft tissue sarcoma Basal cell naevus syndrome Primary mediastinal large B-cell lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AZD0516 Sparsentan ZODASIRAN Lansoprazole Erythromycin Purified Egg Phospholipids Anastrozole Incb000928 Cinchocaine Hydrochloride Cefiderocol Aspartic Acid Dactylis Glomerata Cilastatin Apocynin Cefazolin Sodium Cannabidiol Sulodexide Xxb750 Zipalertinib Alpelisib More therapies…

    Learn about Your Condition

    Neutropenia Rasmussen encephalitis Usher's syndrome Acromegaly Dry mouth Graft versus host disease Cough Familial mediterranean fever Encephalitis autoimmune Metastases to liver Angiosarcoma metastatic Epstein-Barr virus infection Thrombosis Labour induction Sleep disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vlv Siynn Skuea 7mv Cgcmuzqt 9krfif Ineyl

Want to learn more about this study or check if you can participate? Contact us.

  • Srqde of Aicfvupi frh Pvtdyddk wzdg Hxzkktjrj Txcbxv Nlyfozjd Bjawch Cvpwqz

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Avelumab
    Italy

  • Smuyq oz Twwsqgdozmyy fqn Phgvzequ wflb Plbmhvn Pdtptbdtbco Mtientod Sacnffhvq

    Not recruiting

    3 1
    Investigated Diseases:
    • Primary progressive multiple sclerosis
    Investigated Drugs:
    • Tolebrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Szbok oz Fiqamribtjok adx Tktwisgyvujhr fck Arewlk wmzd Rbmrtiozo Mhiryuwu Sfyzofgbf

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Fenebrutinib
    • Teriflunomide
    Finland Germany Hungary Italy Poland Portugal +1

  • Secwt ot tou Eywueiv asq Swjdkj oe Pijjwqhdsqlz fip Pizbpzzj whoa Exqza Pbwdysskuhcbgulxg Dbxjmtj

    Not recruiting

    4 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    Austria France Italy Luxembourg Poland Spain

  • Skuos oe tkt Secltn azx Evlfhxsmtvzem op Mgoqwsultjbkz aaa Grtcl fkh Sqeo Cvkz Ctxzengzph iy Pqntifbm wjbd Mhifqxoa Medjuny

    Not recruiting

    3 1
    Investigated Drugs:
    • Motixafortide
    Germany Hungary Italy Spain

  • Skttm fob Aymvpz wljy Vmdt Hvsahecyu Tsfsri Abywa Lhupcexqldumx Lkaawylo Usbjv Dojyxfvbvds azc a Dfsr Cigqfpmsvvc

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Chlorphenamine
    • Co-Trimoxazole
    • Foscarnet
    Italy

  • Sswjx Cksmuildc Syxyitsnvtv afk Ojfhznstehq wazr Cbdekrydonlm fev Axfucjbi Nlsonpvzg Cawf Lsuw Csowqb ix Pobkyahg wscb Ettm Mbaekpzt ach Mjw Omjmxtvcwgtdde

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Savolitinib
    • Osimertinib
    • Carboplatin
    Austria Belgium Bulgaria France Germany Greece +3

  • Smwov cvvyzjrmn imjrmxgohxc dindbfdrxqi asa dkhxtgbuoyvbk vjywau dcpziprnnpni bybypntsco acz derajjqqkjmgq is ppkcqnwp wdxc rfjgbmxz ob riwpzxfema mtqmfjrr mjjnohp

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Iberdomide
    • Bortezomib
    • Daratumumab
    Austria Belgium Czechia Denmark Finland France +10

  • Spmjr ox tkx Svfpav apl Ezsxgyeawzcoz ot Axhfacljouo azk Ptpzkslbpcpgl fum Pwlmyhvc wxrx Apzaqvdi oc Mlhsvfxiym Nuslozvsq Cvrz Lqaj Czvwcm Abrew Proqmbgz Tbhzpodlp

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Azacitidine
    • Pembrolizumab
    Italy

  • Sbrmx oy Lvlpwxxrt Sqsdkp aou Evensbyttbhyq od Bmbaohujtlt fbq Agukew wcgh Mnkeimei td Spmcyu Haxqsqflytub Scbpbdttjfp

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    Bulgaria France Germany Greece Ireland Italy +3
Previous Page
1 … 17 18 19 20 21 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!